Jury Says Roche's Mircera Infringed Amgen Patents
A federal jury handed Amgen Inc. a big victory Tuesday, ruling that its patents were infringed by Roche Holding AG's generic anemia drug Mircera....To view the full article, register now.
Already a subscriber? Click here to view full article